Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pengo

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
Thrombosis Research|December 13, 2000
Accuracy of a portable prothrombin time monitor (Coagucheck) in patients on chronic oral anticoagulant therapy: a prospective multicenter studyB Cosmi, G Palareti, M Moia, et al.
Lupus|December 22, 2011
A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block?A Ruffatti, O Milanesi, L Chiandetti, et al.
Journal of Thrombosis and Haemostasis : JTH|March 24, 2009
Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-upC Bova, R Pesavento, A Marchiori, et al.
Thrombosis and Haemostasis|December 29, 2000
A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancyG Palareti, C Legnani, A Lee, et al.
Journal of Thrombosis and Haemostasis : JTH|July 24, 2009
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and HaemostasisV Pengo, A Tripodi, G Reber, et al.
Lupus|March 9, 2005
Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort studyA Ruffatti, M Favaro, M Tonello, et al.
Thrombosis Research|February 7, 2018
Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)S Padayattil Jose, A Banzato, P Carraro, et al.
The American Journal of Cardiology|September 2, 1998
Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillationV Pengo, A Zasso, F Barbero, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 29, 2018
Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up studyM Tonello, E Mattia, T Del Ross, et al.
International Journal of Laboratory Hematology|May 11, 2016
Laboratory testing for antiphospholipid syndromeV Pengo, A Banzato, E Bison, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
Thrombosis Research|December 13, 2000
Accuracy of a portable prothrombin time monitor (Coagucheck) in patients on chronic oral anticoagulant therapy: a prospective multicenter studyB Cosmi, G Palareti, M Moia, et al.
Lupus|December 22, 2011
A combination therapy to treat second-degree anti-Ro/La-related congenital heart block: a strategy to avoid stable third-degree heart block?A Ruffatti, O Milanesi, L Chiandetti, et al.
Journal of Thrombosis and Haemostasis : JTH|March 24, 2009
Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-upC Bova, R Pesavento, A Marchiori, et al.
Thrombosis and Haemostasis|December 29, 2000
A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancyG Palareti, C Legnani, A Lee, et al.
Journal of Thrombosis and Haemostasis : JTH|July 24, 2009
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and HaemostasisV Pengo, A Tripodi, G Reber, et al.
Lupus|March 9, 2005
Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort studyA Ruffatti, M Favaro, M Tonello, et al.
Thrombosis Research|February 7, 2018
Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)S Padayattil Jose, A Banzato, P Carraro, et al.
The American Journal of Cardiology|September 2, 1998
Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillationV Pengo, A Zasso, F Barbero, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 29, 2018
Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up studyM Tonello, E Mattia, T Del Ross, et al.
International Journal of Laboratory Hematology|May 11, 2016
Laboratory testing for antiphospholipid syndromeV Pengo, A Banzato, E Bison, et al.
Pageof 17